Position in BIOA
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$1,075,774
-$1,420,501 QoQ
Shares Held
61,508
-67.4% QoQ
Ownership
0.138%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026BANK OF AMERICA CORP /DE/ holds $1,773,009,188 across 50 Drug Manufacturers - Specialty & Generic names. BIOA ranks #39 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
4,831,652 | $571,149,579 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,958,814 | $119,239,475 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
199,426 | $118,255,627 | |
| 4 | HLN |
Haleon plc
|
10,934,228 | $109,451,619 | |
| 5 | VTRS |
Viatris Inc
|
7,259,555 | $98,076,585 | |
| 6 | HIMS |
Hims & Hers Health, Inc.
|
4,357,672 | $90,465,268 | |
| 7 | LQDA |
Liquidia Corp
|
2,287,792 | $86,341,267 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
3,358,215 | $80,362,082 |
All Filings in BIOA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,075,774 | 61,508 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $2,496,275 | 188,683 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $65,378 | 11,119 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $31,395 | 7,602 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $23,033 | 6,126 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $114,751 | 19,819 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $10,919 | 525 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||